The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers-Reference-Cited by-同舟云学术

The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers

Published:2017-06-09 Issue:5 Volume:178 Page:772-780
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Li Ling¹,Duan Wenjing¹^ORCID,Zhang Lei¹,Li Xin¹,Fu Xiaorui¹,Wang Xinhua¹,Wu Jingjing¹,Sun Zhenchang¹,Zhang Xudong¹,Chang Yu¹,Nan Feifei¹,Yan Jiaqin¹,Li Zhaoming¹^ORCID,Young Ken H.²,Zhang Mingzhi¹

Affiliation:

1. Department of Oncology; The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Centre of Henan Province; Zhengzhou Henan China

2. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14763/fullpdf

Reference46 articles.

1. A systematic review and meta-analysis of front-line anthracycline-based chemotherapy regimens for peripheral T-cell lymphoma;Abouyabis;ISRN Hematology,2011

2. Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience;Arkenau;Haematologica,2007

3. Combination therapy for relapsed peripheral T-cell lymphoma: is two better than one?;Bachy;Lancet Haematology,2015

4. Predicting anthracycline benefit: TOP2A and CEP17-not only but also;Bartlett;Journal of Clinical Oncology,2015

5. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer;Bepler;Journal of Clinical Oncology,2006

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results;The Oncologist;2024-05-31

2. Pralatrexate injection combined with CHOP for treatment of PTCL: results from the Fol-CHOP dose-finding phase 1 trial;Blood Advances;2024-01-11

3. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study;Clinical Cancer Research;2024-01-08

4. T-Zell-Lymphome;Non-Hodgkin-Lymphome und Erbliche Tumorsyndrome (ETS);2023-11-23

5. Thirty Years of Experience With Ocular Adnexal T-Cell Lymphoma;Ophthalmic Plastic & Reconstructive Surgery;2023-01-24